You are here

Vascular & Endovascular

 

The FDA on Feb. 15 announced Stryker’s Trevo Retriever clot-removal device can be used up to 24 hours after stroke onset, mirroring the American Heart Association and American Stroke Association’s recently updated guidelines expanding the window for mechanical thrombectomy from 6 to 24 hours.

The FDA cleared Viz.ai’s clinical support tool on Feb. 13, allowing the software that alerts clinicians to the possibility of a stroke to be marketed in the United States.

Short kids grow up to have a higher risk of stroke, according to a study of more than 310,000 Danish schoolchildren with up to eight decades of follow-up.

A team of researchers has developed a risk score containing five readily available factors that predict the odds of stroke for heart attack patients with reduced ejection fraction but without atrial fibrillation (AFib).

People who have migraines are more at risk than the general population for a range of adverse cardiovascular events, according to a study published in The BMJ.

 

Recent Headlines

Ultra-high doses of vitamin D reduce arterial stiffness in black patients

Doses of vitamin D more than six times the recommended daily limit can reduce arterial stiffness in blacks at risk for heart disease, a team of researchers at Augusta University in Georgia have found.

Effective stroke treatment in young women could hinge on multidisciplinary approach

A multidisciplinary approach to diagnosing and treating stroke could be critical for improved survival in young women, a study published in the January issue of Academic Emergency Medicine suggests.

A popular anti-smoking drug could threaten heart health

A globally popular drug used to help smokers quit could be doing more harm than good, according to observational research out of Canada—while the medication can more than triple a smoker’s chances of nixing the habit, it could also substantially increase the risk of experiencing a cardiovascular event.

COPD patients beginning inhaler therapy at greater short-term risk for CVD

People with chronic obstructive pulmonary disease (COPD) who used long-acting inhaled bronchodilators for the first time demonstrated a 50 percent heightened risk of cardiovascular disease (CVD) in the first 30 days after taking the medicine, according to a study published in JAMA Internal Medicine.

Women more likely to experience blood vessel constriction in stressful situations

Women with heart disease are more prone to mental stress-induced ischemia than men, potentially raising the risk of adverse cardiovascular events and death, according to a new study in Arteriosclerosis, Thrombosis and Vascular Biology.

Antiepileptic drug cuts risk of recurrent stroke by 53%

An epilepsy drug that inhibits the histone deacetylase 9 (HDAC9) gene was associated with a significantly reduced risk of recurrent stroke in a pooled cohort study of nearly 12,000 patients.

Women with restless legs syndrome more likely to die from cardiovascular disease

Women with physician-diagnosed restless legs syndrome (RLS) have a higher risk of dying from cardiovascular causes than their healthy counterparts, a study published this month in Neurology states.

Standardized scores accurately recommend stroke patient's placement after discharge

Meta-analyses of five large-scale studies have proven the efficacy of standardized rating scales in determining a stroke patient’s placement after hospital discharge, according to research published in the January issue of the Journal of Neurological Physical Therapy.

Erectile dysfunction proves an early predictor of subclinical CVD

Erectile dysfunction could be an early warning sign of subclinical cardiovascular disease (CVD), especially in young men whose CVD risks aren’t steadily monitored, researchers reported in Vascular Medicine this December.

Study finds death receptors can indicate future CVD, diabetes risk

A Swedish study of nearly 5,000 patients has proven the efficacy of death receptors as markers for type 2 diabetes and cardiovascular disease, according to research published in EBioMedicine.

Pages